# Clinical and biological features of complicated and asymptomatic malaria among PLHIV and HIV-negative adults: An observational study in Libreville, Gabon

**Authors:** Bridy Chesly Moutombi Ditombi, Charleine Manomba Boulingui, Ornella Anaïse Mbang Nguema, Coella Joyce Mihindou, Bedrich Pongui Ngondza, Jacques Mari Ndong Ngomo, Magalie Essomeyo Mebale, Michèle-Marion Ntsame Owono, Ardin Dimitri Mabicka Moussavou, Christian Mayandza, Noé Patrick Mbondoukwé, Helena Noeline Kono, Marielle Karine Bouyou Akotet

PMC · DOI: 10.1371/journal.pone.0327068 · PLOS One · 2026-02-17

## TL;DR

This study compares malaria symptoms in HIV-positive and HIV-negative adults in Gabon, finding that severe malaria is more common in those with HIV.

## Contribution

The study provides new insights into the differing clinical manifestations of malaria in PLHIV and HIV-negative individuals in an endemic region.

## Key findings

- Severe malaria was significantly more common in PLHIV compared to HIV-negative individuals.
- Asymptomatic malaria was more frequent in HIV-negative participants than in PLHIV.
- CTX chemoprophylaxis was associated with reduced Plasmodium falciparum parasitemia in PLHIV.

## Abstract

Malaria and HIV remain major public health challenges in sub-Saharan Africa. This study described the spectrum of malaria in people living with HIV (PLHIV) and HIV-negative adults in Gabon, where both diseases are endemic.

A cross-sectional study was conducted at the Centre Hospitalier Universitaire de Libreville from September 2021 to October 2022. Asymptomatic and febrile PLHIV and HIV negative volunteers were screened for malaria and Plasmodium-infected individuals enrolled in the study. Data collected included socio-demographic characteristics, clinical presentation, cotrimoxazole use, antiretroviral treatment, and laboratory parameters, such as parasitaemia, haemoglobin levels and CD4+ cell counts. Data from PLHIV and HIV-negative participants were compared using bivariate and multivariable logistic regression analysis.

Among the 1.192 individuals tested, 513 were PLHIV and 599 HIV-negative. Overall, 56 Plasmodium falciparum-infected PLHIV and 66 HIV-negative individuals were enrolled. Asymptomatic malaria was more frequent among HIV-negative participants (60.6% vs 25.0%), while severe malaria was significantly more common among HIV-positive patients (48.2% vs 12.1%) (p < 0.01). Prostration (16.7%), repeated seizures (14.3%), impaired consciousness (26.2%), severe anaemia (14.3%) and hypoglycemia (11.9%) predominated in PLHIV. Conversely, vomiting (26.9%) and high parasitemia (23.1%) were more frequent in HIV-negative patients. CTX chemoprophylaxis was associated with a reduction in Plasmodium falciparum parasitemia (p = 0.03). The median CD4 + cell count was significantly lower in PLHIV with severe malaria (150 [IQR: 90-204] cells/µL) compared to those with asymptomatic (304 [IQR: 189-476] cells/µL) (p = 0.018).

Compared to HIV negative, asymptomatic malaria was less frequent while severe malaria predominantly affects PLHIV with advanced immunosuppression, highlighting the importance of early detection and management of co-infection to reduce morbidity. Further studies are needed to investigate the neurological manifestations and the impact of prophylactic strategies in Libreville.

## Linked entities

- **Diseases:** malaria (MONDO:0005136), hypoglycemia (MONDO:0004946)
- **Species:** Plasmodium falciparum (taxon 5833)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, LIX1 (limb and CNS expressed 1) [NCBI Gene 167410] {aka C5orf11, Lft}
- **Diseases:** syphilis (MESH:D013587), inflammation (MESH:D007249), circulatory collapse (MESH:D012769), opportunistic infection (MESH:D009894), weakness (MESH:D018908), Plasmodium (P.) falciparum-infected (OMIM:248310), breathing (MESH:D004417), Hepatitis C (MESH:D019698), Hepatitis B (MESH:D006509), febrile (MESH:D000071072), bleeding (MESH:D006470), organ dysfunction (MESH:D009102), AIDS (MESH:D000163), unresponsiveness (MESH:C567934), acute renal failure (MESH:D058186), jaundice (MESH:D007565), febrile illness (MESH:D005334), acute respiratory distress syndrome (MESH:D012128), hematologic alterations (MESH:D019337), convulsions (MESH:D012640), neurological symptoms (MESH:D009461), cryptococcosis (MESH:D003453), Vomiting (MESH:D014839), hemolysis (MESH:D006461), HIV/AIDS (MESH:D016263), protozoal infections (MESH:D020808), haemorrhagic abnormalities (MESH:D006474), symptoms (MESH:D012816), Co-infection (MESH:D060085), Anemia (MESH:D000740), nutritional deficiencies (MESH:D044342), micronutrient deficiencies (MESH:D007153), death (MESH:D003643), hematologic toxicity (MESH:D006402), impaired consciousness (MESH:D003244), malabsorption (MESH:D008286), acute pulmonary oedema (MESH:D012120), immune dysfunction (MESH:D007154), COVID-19 (MESH:D000086382), marrow suppression (MESH:D001855), infected (MESH:D007239), hypoglycemia (MESH:D007003), cerebral malaria (MESH:D016779), toxicity (MESH:D064420), malaria parasitemia (MESH:D018512), tuberculosis (MESH:D014376), Liver cytolysis (MESH:D017093), parasitic infections (MESH:D010272), prostration (MESH:D006359), anaemia (MESH:D000743), intestinal helminth infections (MESH:D007410), asthenia (MESH:D001247), HIV (MESH:D015658), Plasmodium parasitaemia (MESH:D008288), cerebral toxoplasmosis (MESH:D016781), Infectious Diseases (MESH:D003141), toxoplasmosis (MESH:D014123), severe (MESH:D045169), coma (MESH:D003128)
- **Chemicals:** methanol (MESH:D000432), tenofovir (MESH:D000068698), Giemsa (MESH:D001399), water (MESH:D014867), DTG (MESH:C562325), iron (MESH:D007501), blood glucose (MESH:D001786), ART (-), AZT (MESH:D015215), oil (MESH:D009821), vitamin B12 (MESH:D014805), CTX (MESH:D015662), folate (MESH:D005492), creatinine (MESH:D003404), glucose (MESH:D005947)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Homo sapiens (human, species) [taxon 9606], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833], Plasmodium sp. (species) [taxon 31272]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912685/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12912685/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912685/full.md

---
Source: https://tomesphere.com/paper/PMC12912685